Skip to main content
. 2020 Jun 9;21(5):256–263. doi: 10.1111/1751-2980.12870

TABLE 3.

Rates of adverse events, compliance and symptom improvement (n/N, %)

BA group TF group P value
Overall adverse events 61/329 (18.5) 86/329 (26.1) 0.024
Severe adverse events 3/329 (0.9) 4/329 (1.2) 1.000
Compliance rate 305/329 (92.7) 296/329 (90.0) 0.267
2‐week symptom improvement 196/283 (69.3) 166/266 (62.4) 0.105
6‐week symptom improvement 239/283 (84.5) 216/266 (81.2) 0.365

Abbreviations: BA, berberine and amoxicillin; TF, tetracycline and furazolidone.